HKPD
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
Capitalization
4.73M
Intraday BUY SELL Signals
PETS
Price
$1.18
Change
-$0.01 (-0.84%)
Updated
Oct 22 closing price
Capitalization
25.58M
19 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HKPD vs PETS

HKPD vs PETS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HKPD vs. PETS commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HKPD is a Hold and PETS is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HKPD with price predictions
Oct 22, 2026

HKPD in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 22, 2026

HKPD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 14 of 15 cases where HKPD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for HKPD's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Moving Average Convergence Divergence (MACD) for HKPD just turned positive on September 22, 2026. Looking at past instances where HKPD's MACD turned positive, the stock continued to rise in 8 of 11 cases over the following month. The odds of a continued upward trend are 73%.

Following a +2.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where HKPD advanced for three days, in 56 of 63 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 8 of 8 cases where HKPD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HKPD as a result. In 26 of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HKPD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for HKPD entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.566) is normal, around the industry mean (11.659). P/E Ratio (6.136) is within average values for comparable stocks, (10.893). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.146) among similar stocks. P/S Ratio (0.147) is also within normal values, averaging (4.260).

The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. HKPD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HKPD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.

A.I.Advisor
a Summary for PETS with price predictions
Oct 22, 2026

PETS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for PETS turned positive on October 20, 2026. Looking at past instances where PETS's MACD turned positive, the stock continued to rise in 34 of 47 cases over the following month. The odds of a continued upward trend are 72%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

PETS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PETS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for PETS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.113) is normal, around the industry mean (1.309). P/E Ratio (-0.861) is within average values for comparable stocks, (-2.136). Projected Growth (PEG Ratio) (1.270) is also within normal values, averaging (0.947). PETS has a moderately high Dividend Yield (1.017) as compared to the industry average of (0.254). P/S Ratio (0.200) is also within normal values, averaging (2.504).

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. PETS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PETS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

FUNDAMENTALS RATINGS
PETS: Fundamental Ratings
PETS
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HKPDPETS
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
89%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (HKPD: $0.10 vs. PETS: $1.19)
Brand notoriety: HKPD and PETS are both not notable
HKPD represents the Medical Distributors, while PETS is part of the Drugstore Chains industry
Current volume relative to the 65-day Moving Average: HKPD: 94% vs. PETS: 68%
Market capitalization -- HKPD: $4.73M vs. PETS: $25.58M
HKPD [@Medical Distributors] is valued at $4.73M. PETS’s [@Drugstore Chains] market capitalization is $25.58M. The market cap for tickers in the [@Medical Distributors] industry ranges from $44.8K to $118.4B. The market cap for tickers in the [@Drugstore Chains] industry ranges from $36.55K to $14.27B. The average market capitalization across the [@Medical Distributors] industry is $23.28B. The average market capitalization across the [@Drugstore Chains] industry is $83.33M.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HKPD’s FA Score shows that 1 FA rating(s) are green while PETS’s FA Score has 2 green FA rating(s).

  • HKPD’s FA Score: 1 green, 4 red.
  • PETS’s FA Score: 2 green, 3 red.
According to our system of comparison, PETS is a better buy in the long-term than HKPD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HKPD’s TA Score shows that 3 TA indicator(s) are bullish while PETS’s TA Score has 2 bullish TA indicator(s).

  • HKPD’s TA Score: 3 bullish, 4 bearish.
  • PETS’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, PETS is a better buy in the short-term than HKPD.

Price Growth

HKPD (@Medical Distributors) experienced а -9.73% price change this week, while PETS (@Drugstore Chains) price change was -0.83% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -6.66%. For the same industry, the average monthly price growth was -8.84%, and the average quarterly price growth was -24.09%.

The average weekly price growth across all stocks in the @Drugstore Chains industry was +33.58%. For the same industry, the average monthly price growth was +10.65%, and the average quarterly price growth was -48.09%.

Reported Earning Dates

PETS is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Medical Distributors (-6.66% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

@Drugstore Chains (+33.58% weekly)

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

View a ticker or compare two or three
HKPD
Daily Signal:
Gain/Loss:
PETS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

HKPD and

Correlation & Price change

A.I.dvisor tells us that HKPD and SCNX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKPD and SCNX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKPD
1D Price
Change %
HKPD100%
-5.88%
SCNX - HKPD
31%
Poorly correlated
-4.65%
COSM - HKPD
20%
Poorly correlated
-9.87%
YI - HKPD
11%
Poorly correlated
-2.85%
HITI - HKPD
9%
Poorly correlated
-1.67%
FOCL - HKPD
7%
Poorly correlated
-5.03%
More

PETS and

Correlation & Price change

A.I.dvisor tells us that PETS and LFMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PETS and LFMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PETS
1D Price
Change %
PETS100%
-0.84%
LFMD - PETS
22%
Poorly correlated
+1.40%
HITI - PETS
20%
Poorly correlated
-1.67%
YI - PETS
19%
Poorly correlated
-2.85%
LFMDP - PETS
5%
Poorly correlated
-1.04%
HKPD - PETS
2%
Poorly correlated
-5.88%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSC338.2310.14
+3.09%
Norfolk Southern Corp
HFWA28.520.84
+3.03%
Heritage Financial Corp
ASPC10.700.06
+0.56%
A Spac III Acquisition Corp
MCGA10.40N/A
+0.05%
Yorkville Acquisition Corp.
RGC9.81-0.99
-9.17%
Regencell Bioscience Holdings Limited